OPTN - OptiNose Quarterly EPS earnings growth
High promotion costs are temporarily limiting the operational efficiency of OptiNose, Inc. (OPTN). Quarterly earnings per share growth helps assess business resilience, with the current level sitting around -2.50. The company's success relies on XHANCE system sales and insurance provider recognition. Simultaneously, the issuer must fight for prescriptions amid intense pressure from affordable generics.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_OPTN_-_OptiNose-Inc._-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "optinose.com (OPTN): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 05/31/2025 | 👁️GURU.Markets👁️")
Analytical breakdowns for OptiNose Corp (OPTN)
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
- earnings and market multiples details:
OPTN - Company Net Income|Expected Profit OptiNose, Inc.|OPTN - Business Payback Period|Forward P/E Multiple Optinose|OPTN - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Optinose|OPTN - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) OptiNose|OPTN - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months optinose.com|OPTN - Earnings per share growth this year|Earnings growth forecast for next year OptiNose, Inc.
- sales revenue and business income indicators:
Fundamental company valuation:OptiNose - OPTN
Quarterly EPS growth measures the percentage change in net income per share, allowing for an assessment of business scaling efficiency and the pace of shareholder value generation. By analyzing the quarterly EPS trend profile, an investor can see the impact of the commercialization of a unique nasopharyngeal drug delivery system and the trust of the ENT community on the actual profitability of OptiNose, Inc. during periods of expansion.
Competitors of OptiNose, Inc. (OPTN)
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Alvotech S.A. (ALVO) - Earnings per share growth in annualized terms for the last twelve months|LQDA - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months GLPG|ANIP (ANI Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|MNKD: Year-over-year earnings per share growth rate for the last twelve months|AMPH (Amphastar Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|Pacira Pharmaceuticals (PCRX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|Theravance Corp - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Aquestive Therapeutics AQST|scPharmaceuticals, Inc. (SCPH) - Earnings per share growth in annualized terms for the last twelve months|TECX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Tonix Pharma TNXP|SXTC: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Eupraxia Pharmaceuticals Inc. (EPRX)|Year-over-year net earnings per share growth for the last 12 months BHST|EXOZ: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORMP|Year-over-year net earnings per share change for the last twelve months enterabio.com|Year-over-year earnings per share growth for the last twelve months MindWalk HYFT|ABVC: Year-over-year earnings per share growth for the last 12 months|Cumberland Pharmaceuticals - Quarterly EPS earnings growth|quantumbiopharma.com (QNTM) - Year-over-year net earnings per share growth for the last 12 months|FGEN (FibroGen) - Year-over-year net earnings per share growth for the last 12 months|TELO - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Rani Therapeutics Holdings|Earnings per share growth in annualized terms for the last twelve months Synergy CHC Corporation SNYR|Year-over-year earnings per share growth for the last twelve months Rallybio Corporation (RLYB)|LEXX: Year-over-year net earnings per share trend for the last twelve months|Pulmatrix - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months PTHL (Pheton Holdings Limited)|APM - Year-over-year earnings per share growth for the last twelve months|LYRA (Lyra Therapeutics Inc) - Year-over-year earnings per share growth for the last 12 months|Impact BioMedical (IBO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months TNFA (TNF Pharmaceuticals, Inc.)|YCBD (cbdMD Inc.) - Quarterly EPS earnings growth|PRFX: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth CYTO|Quarterly EPS earnings growth Lipella Pharma (LIPO)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals PIRS|Year-over-year earnings per one share growth for the last 12 months PROC|PTPI - Year-over-year earnings per share growth for the last twelve months|Qilian International Holding Group (QLI) - Year-over-year net earnings per share growth for the last 12 months|SLRN: Quarterly EPS earnings growth|TFF Pharmaceuticals, Inc (TFFP) - Quarterly EPS earnings growth
